drug

nitric oxide

1 story · latest Sep 24, 2026

Status: FDA approved Dec 1999 · NDA020845, NDA202860
Brands: Genosyl, Inomax

Timeline

Novlead registers post-market study of INOwill N200 nitric oxide device for neonatal PPHN

Sep 24Trial updatenitric oxide

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.